{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:00:07Z","timestamp":1791644407316,"version":"4.3.4"},"reference-count":137,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN275201300006C"],"award-info":[{"award-number":["HHSN275201300006C"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.ajog.2023.10.002","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T02:02:05Z","timestamp":1696557725000},"page":"450.e1-450.e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors"],"prefix":"10.1016","volume":"230","author":[{"given":"Tinnakorn","family":"Chaiworapongsa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4448-5121","authenticated-orcid":false,"given":"Roberto","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nardhy","family":"Gomez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manaphat","family":"Suksai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahiana M.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M.","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awoniyi","family":"Awonuga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi L.","family":"Tarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.10.002_bib1","doi-asserted-by":"crossref","first-page":"l2381","DOI":"10.1136\/bmj.l2381","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2023.10.002_bib2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajog.2023.10.002_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41581-019-0119-6","article-title":"Pre-eclampsia: pathogenesis, novel diagnostics and therapies","volume":"15","author":"Phipps","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajog.2023.10.002_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.10.002_bib5","doi-asserted-by":"crossref","first-page":"S786","DOI":"10.1016\/j.ajog.2021.12.001","article-title":"Preeclampsia and eclampsia: the conceptual evolution of a syndrome","volume":"226","author":"Erez","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib6","doi-asserted-by":"crossref","first-page":"S973","DOI":"10.1016\/j.ajog.2020.10.025","article-title":"Animal models of preeclampsia: investigating pathophysiology and therapeutic targets","volume":"226","author":"Bakrania","year":"2022","journal-title":"Am J Obstet\u00a0Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib7","doi-asserted-by":"crossref","first-page":"S907","DOI":"10.1016\/j.ajog.2020.09.047","article-title":"Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways","volume":"226","author":"Redman","year":"2022","journal-title":"Am J\u00a0Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib8","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"Magee","year":"2022","journal-title":"Preeclampsia. N Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib9","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2021.05.043","article-title":"Electronic address: pubs@smfm.org. Executive summary: workshop on Preeclampsia, January 25-26, 2021, cosponsored by the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation","volume":"225","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib10","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib11","article-title":"Trends in the\u00a0incidence of new-onset hypertensive disorders of pregnancy among rural and urban areas\u00a0in the United States, 2007 to 2019","volume":"11","author":"Cameron","year":"2022","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"392","key":"10.1016\/j.ajog.2023.10.002_bib12","first-page":"1","article-title":"Increases in prepregnancy obesity: United States, 2016-2019","author":"Driscoll","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2023.10.002_bib13","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1111\/nure.12055","article-title":"Epidemiology of preeclampsia: impact of obesity","volume":"71","author":"Jeyabalan","year":"2013","journal-title":"Nutr Rev"},{"key":"10.1016\/j.ajog.2023.10.002_bib14","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/1471-0528.15661","article-title":"Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts","volume":"126","author":"Santos","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.10.002_bib15","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ajog.2017.04.032","article-title":"Short-term costs of preeclampsia to the United States health care system","volume":"217","author":"Stevens","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1081\/PRG-120021060","article-title":"Subclassification of preeclampsia","volume":"22","author":"von Dadelszen","year":"2003","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2023.10.002_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1161\/HYPERTENSIONAHA.113.02664","article-title":"Strategy for standardization of preeclampsia research study design","volume":"63","author":"Myatt","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.10.002_bib18","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/HYPERTENSIONAHA.120.14781","article-title":"Subtypes of preeclampsia:\u00a0recognition and determining clinical usefulness","volume":"77","author":"Roberts","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.10.002_bib19","doi-asserted-by":"crossref","first-page":"S844","DOI":"10.1016\/j.ajog.2021.11.1356","article-title":"The etiology of preeclampsia","volume":"226","author":"Jung","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib20","doi-asserted-by":"crossref","first-page":"S1006","DOI":"10.1016\/j.ajog.2020.10.052","article-title":"Preeclampsia has two phenotypes which require different treatment strategies","volume":"226","author":"Masini","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib21","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ajog.2023.10.002_bib22","doi-asserted-by":"crossref","first-page":"615.e1","DOI":"10.1016\/j.ajog.2022.04.015","article-title":"Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology","volume":"227","author":"Romero","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib23","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2017.11.561","article-title":"Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis","volume":"218","author":"Roberge","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2020.100184","article-title":"Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race","volume":"2","author":"Tolcher","year":"2020","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajog.2023.10.002_bib26","doi-asserted-by":"crossref","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ajog.2023.10.002_bib28","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/uog.26291","article-title":"Prediction of hypertensive disorders after screening at 36 weeks\u2019 gestation: comparison of angiogenic markers with competing-risks model","volume":"62","author":"Schiattarella","year":"2023","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase\u00a01 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2023.10.002_bib30","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib31","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of\u00a0the vascular endothelial growth factor system\u00a0in the pathophysiology of preeclampsia. Young investigator award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib32","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/01.HYP.0000258404.21552.a3","article-title":"Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion","volume":"49","author":"Stepan","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.10.002_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib35","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/1471-0528.15042","article-title":"Angiogenic factors: potential to change clinical practice in pre-eclampsia?","volume":"125","author":"Cerdeira","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.10.002_bib36","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/HYPERTENSIONAHA.119.13360","article-title":"Predictive performance of PlGF (placental growth factor) for screening preeclampsia in asymptomatic women: a systematic review and meta-analysis","volume":"74","author":"Agrawal","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.10.002_bib37","doi-asserted-by":"crossref","first-page":"S1019","DOI":"10.1016\/j.ajog.2020.10.022","article-title":"Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders","volume":"226","author":"Rana","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib38","doi-asserted-by":"crossref","first-page":"S1035","DOI":"10.1016\/j.ajog.2021.11.1350","article-title":"Discovery of antiangiogenic factors in the pathogenesis of preeclampsia","volume":"226","author":"Karumanchi","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib39","doi-asserted-by":"crossref","first-page":"S1037","DOI":"10.1016\/j.ajog.2020.10.028","article-title":"Real-world data on the\u00a0clinical use of angiogenic factors in pregnancies with placental dysfunction","volume":"226","author":"Dathan-Stumpf","year":"2022","journal-title":"Am J Obstet\u00a0Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib40","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the\u00a0sFlt-1\/PlGF ratio in the prediction, diagnosis\u00a0and management of preeclampsia","volume":"27","author":"Verlohren","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2023.10.002_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth\u00a0factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib42","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2006.01.014","article-title":"Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction","volume":"195","author":"Crispi","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib43","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstr\u00f6m","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"Powers","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.10.002_bib45","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3109\/14767058.2011.589932","article-title":"Maternal plasma concentrations of angiogenic\/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia","volume":"24","author":"Chaiworapongsa","year":"2011","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib46","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia","volume":"125","author":"Rana","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2023.10.002_bib47","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2013.01.016","article-title":"Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia","volume":"208","author":"Chaiworapongsa","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib48","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/14767058.2013.806905","article-title":"Plasma concentrations of angiogenic\/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study","volume":"27","author":"Chaiworapongsa","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib50","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3109\/10641955.2016.1148162","article-title":"KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes","volume":"35","author":"Salahuddin","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2023.10.002_bib51","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","article-title":"Prediction of preeclampsia using the soluble fms-Like tyrosine kinase 1 to placental growth factor ratio: a prospective cohort study of unselected nulliparous women","volume":"69","author":"Sovio","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.10.002_bib52","doi-asserted-by":"crossref","first-page":"259.e1","DOI":"10.1016\/j.ajog.2019.09.003","article-title":"Placental growth factor predicts time to delivery in women with signs or symptoms of early preterm preeclampsia: a prospective multicenter study","volume":"222","author":"Barton","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib53","doi-asserted-by":"crossref","first-page":"305.e1","DOI":"10.1016\/j.ajog.2021.03.041","article-title":"Angiogenic markers and their longitudinal change for predicting adverse outcomes in\u00a0pregnant women with chronic hypertension","volume":"225","author":"Binder","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-Like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.10.002_bib55","doi-asserted-by":"crossref","first-page":"569.e1","DOI":"10.1016\/j.ajog.2022.11.001","article-title":"Preeclampsia at term can be classified into\u00a02 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood","volume":"228","author":"Chaiworapongsa","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib56","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1600-0897.1997.tb00222.x","article-title":"Placental cytokines and the pathogenesis of preeclampsia","volume":"37","author":"Conrad","year":"1997","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2023.10.002_bib58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9378(98)70254-6","article-title":"Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis","volume":"179","author":"Sacks","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib59","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"Redman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib60","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1067\/mob.2001.117311","article-title":"Phenotypic and metabolic characteristics\u00a0of monocytes and granulocytes in preeclampsia","volume":"185","author":"Gervasi","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/jmf.12.1.19.27","article-title":"Soluble adhesion molecule profile in normal pregnancy and pre-eclampsia","volume":"12","author":"Chaiworapongsa","year":"2002","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib62","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.2741\/2266","article-title":"Placental cytokines and preeclampsia","volume":"12","author":"Keelan","year":"2007","journal-title":"Front Biosci"},{"key":"10.1016\/j.ajog.2023.10.002_bib63","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11906-007-0088-1","article-title":"Inflammatory cytokines in the pathophysiology of hypertension during preeclampsia","volume":"9","author":"LaMarca","year":"2007","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ajog.2023.10.002_bib64","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00281-007-0071-6","article-title":"Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia","volume":"29","author":"Rusterholz","year":"2007","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ajog.2023.10.002_bib65","doi-asserted-by":"crossref","first-page":"629.e1","DOI":"10.1016\/j.ajog.2015.11.015","article-title":"Maternal plasma angiogenic index-1 (placental growth factor\/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study","volume":"214","author":"Korzeniewski","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib66","first-page":"159","article-title":"ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib67","doi-asserted-by":"crossref","first-page":"518.e1","DOI":"10.1016\/j.ajog.2020.11.004","article-title":"Impact of new definitions of preeclampsia at term on identification of\u00a0adverse maternal and perinatal outcomes","volume":"224","author":"Lai","year":"2021","journal-title":"Am\u00a0J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0029-7844(95)00386-X","article-title":"A\u00a0United States national reference for fetal growth","volume":"87","author":"Alexander","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib69","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A\u00a0prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"SupplA","key":"10.1016\/j.ajog.2023.10.002_bib70","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/j.placenta.2005.02.009","article-title":"Placental diagnostic criteria and clinical correlation - a workshop report","volume":"26","author":"Redline","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2023.10.002_bib71","doi-asserted-by":"crossref","first-page":"698","DOI":"10.5858\/arpa.2015-0225-CC","article-title":"Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group consensus statement","volume":"140","author":"Khong","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib72","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1600-0897.2012.01158.x","article-title":"Biomarkers of coagulation, inflammation, and angiogenesis are independently associated with preeclampsia","volume":"68","author":"Boij","year":"2012","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2023.10.002_bib73","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/imm.12757","article-title":"Association between cytokine profile and transcription factors produced by T-cell subsets in early- and late-onset pre-eclampsia","volume":"152","author":"Ribeiro","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.ajog.2023.10.002_bib74","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/bph.14466","article-title":"Inflammatory mediators: a causal link to hypertension during preeclampsia","volume":"176","author":"Cornelius","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ajog.2023.10.002_bib75","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/JLB.5RU1120-787RR","article-title":"Cellular immune responses in the pathophysiology of preeclampsia","volume":"111","author":"Miller","year":"2022","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.ajog.2023.10.002_bib76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/NNR.0000000000000285","article-title":"Inflammatory markers and preeclampsia: a systematic review","volume":"67","author":"Black","year":"2018","journal-title":"Nurs Res"},{"key":"10.1016\/j.ajog.2023.10.002_bib77","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.cyto.2011.09.021","article-title":"A\u00a0meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia","volume":"56","author":"Xie","year":"2011","journal-title":"Cytokine"},{"key":"10.1016\/j.ajog.2023.10.002_bib78","first-page":"412","article-title":"Tumor necrosis factor-alpha, interleukin-6, and interleukin-10 levels are altered in preeclampsia: a systematic review and meta-analysis","volume":"70","author":"Lau","year":"2013","journal-title":"Am\u00a0J\u00a0Reprod Immunol"},{"key":"10.1016\/j.ajog.2023.10.002_bib79","doi-asserted-by":"crossref","first-page":"S895","DOI":"10.1016\/j.ajog.2020.09.026","article-title":"Failure of physiological transformation and spiral artery atherosis: their roles in preeclampsia","volume":"226","author":"Staff","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib80","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes","volume":"221","author":"Brosens","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib81","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2016.12.029","article-title":"Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta","volume":"216","author":"Labarrere","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib82","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI119388","article-title":"Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?","volume":"99","author":"Zhou","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2023.10.002_bib83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the\u00a0sVEGFR-1 concentration in maternal plasma\u00a0in preeclampsia has a uterine origin","volume":"18","author":"Bujold","year":"2005","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib84","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/aji.12547","article-title":"Inhibition of T-cell activation attenuates hypertension, TNF\u03b1, IL-17, and blood-brain barrier permeability in pregnant rats with angiogenic imbalance","volume":"76","author":"Bean","year":"2016","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2023.10.002_bib85","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/10641950902777721","article-title":"Exogenous soluble VEGF receptor-1 (sFlt-1) regulates Th1\/Th2 cytokine production from normal placental explants via intracellular calcium","volume":"28","author":"Xu","year":"2009","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2023.10.002_bib86","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/01.HYP.0000175476.26719.36","article-title":"Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha","volume":"46","author":"LaMarca","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.10.002_bib87","first-page":"1582","article-title":"Hypoxia stimulates cytokine production by villous explants from the human placenta","volume":"82","author":"Benyo","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.ajog.2023.10.002_bib88","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.placenta.2014.01.008","article-title":"Placental perfusion in normal pregnancy and early and late preeclampsia: a magnetic resonance imaging study","volume":"35","author":"Sohlberg","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2023.10.002_bib89","doi-asserted-by":"crossref","first-page":"337.e1","DOI":"10.1016\/j.ajog.2012.06.047","article-title":"Systemic inflammatory stimulation by microparticles derived from hypoxic trophoblast as a model for inflammatory\u00a0response in preeclampsia","volume":"207","author":"Lee","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1095\/biolreprod.111.097014","article-title":"Heightened pro-inflammatory effect of preeclamptic placental microvesicles on peripheral blood immune cells in humans","volume":"86","author":"Holder","year":"2012","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2023.10.002_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.676056","article-title":"Syncytiotrophoblast extracellular vesicles from late-onset preeclampsia placentae suppress pro-inflammatory immune response in THP-1 macrophages","volume":"12","author":"Awoyemi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajog.2023.10.002_bib92","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.4049\/jimmunol.178.9.5949","article-title":"Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles","volume":"178","author":"Germain","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2023.10.002_bib93","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cyto.2018.02.007","article-title":"Induction of systemic inflammation by hyaluronan and hsp70 in women with pre-eclampsia","volume":"105","author":"Rom\u00e3o-Veiga","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.ajog.2023.10.002_bib94","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1447-0756.2007.00551.x","article-title":"TNF-alpha from monocyte of patients with pre-eclampsia-induced apoptosis in human trophoblast cell line","volume":"33","author":"Seki","year":"2007","journal-title":"J\u00a0Obstet Gynaecol Res"},{"key":"10.1016\/j.ajog.2023.10.002_bib95","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.preghy.2012.04.174","article-title":"PP063. TLR-4 expression and pro-inflammatory cytokine production by peripheral blood monocytes from preeclamptic women","volume":"2","author":"Romao","year":"2012","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2023.10.002_bib96","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jri.2017.05.002","article-title":"Ligands of toll-like receptors 2\/4 differentially alter markers of inflammation, adhesion and angiogenesis by monocytes from women with pre-eclampsia in co-culture with endothelial cells","volume":"121","author":"Al-Ofi","year":"2017","journal-title":"J\u00a0Reprod Immunol"},{"key":"10.1016\/j.ajog.2023.10.002_bib97","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.preghy.2020.06.002","article-title":"Increased TLR4 pathway activation and cytokine imbalance led to lipopolysaccharide tolerance in monocytes from preeclamptic women","volume":"21","author":"Rom\u00e3o-Veiga","year":"2020","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2023.10.002_bib98","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/cvr\/cvq346","article-title":"Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signalling","volume":"89","author":"Cindrova-Davies","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ajog.2023.10.002_bib99","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/ndt\/gfab175","article-title":"Renal dysfunction and podocyturia in pre-eclampsia may be explained by increased urinary VEGF","volume":"37","author":"Valsecchi","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ajog.2023.10.002_bib100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5414\/CN107321","article-title":"From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia","volume":"78","author":"Wagner","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.ajog.2023.10.002_bib101","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/01.HYP.0000238442.33463.94","article-title":"Hypertension produced by reductions in uterine perfusion\u00a0in the pregnant rat: role of interleukin 6","volume":"48","author":"Gadonski","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.10.002_bib102","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14038","article-title":"Chronic infusion of interleukin-17 promotes hypertension, activation of cytolytic natural killer cells, and vascular dysfunction in pregnant rats","volume":"7","author":"Travis","year":"2019","journal-title":"Physiol Rep"},{"key":"10.1016\/j.ajog.2023.10.002_bib103","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.preghy.2021.02.009","article-title":"Interleukin-17 induces hypertension but does not impair cerebrovascular function in pregnant rats","volume":"24","author":"Duncan","year":"2021","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2023.10.002_bib104","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/14767050701483298","article-title":"CXCL10\/IP-10: a missing link between inflammation and anti-angiogenesis in preeclampsia?","volume":"20","author":"Gotsch","year":"2007","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib105","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/TP.0000000000000419","article-title":"Elevated urinary CXCL10-to-creatinine ratio is associated with subclinical and\u00a0clinical rejection in pediatric renal transplantation","volume":"99","author":"Blydt-Hansen","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.ajog.2023.10.002_bib106","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1016\/j.ajog.2015.08.041","article-title":"Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance","volume":"213","author":"Kim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib107","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1515\/jpm-2017-0042","article-title":"Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: a marker of allograft rejection","volume":"46","author":"Maymon","year":"2018","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib108","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/CS20150666","article-title":"Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases","volume":"130","author":"Altara","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ajog.2023.10.002_bib109","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijcard.2017.02.011","article-title":"Serum CXCL10 and CXCL12 chemokine levels are associated with the severity of coronary artery disease and coronary artery occlusion","volume":"233","author":"Tavakolian Ferdousie","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ajog.2023.10.002_bib110","first-page":"434","article-title":"The interleukin-12 and interleukin-12 receptor system in normal and transformed human B lymphocytes","volume":"87","author":"Airoldi","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.ajog.2023.10.002_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00430-003-0186-x","article-title":"The power of combinatorial immunology: il-12 and IL-12-related dimeric cytokines in infectious diseases","volume":"193","author":"H\u00f6lscher","year":"2004","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.ajog.2023.10.002_bib112","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fimmu.2018.00809","article-title":"Expression and function of IL12\/23 related cytokine subunits (p35, p40, and p19) in giant-cell arteritis lesions: contribution of p40 to Th1- and Th17-mediated inflammatory pathways","volume":"9","author":"Esp\u00edgol-Frigol\u00e9","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajog.2023.10.002_bib113","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10641955.2013.784788","article-title":"Clinical characterization and outcomes of preeclampsia with normal angiogenic profile","volume":"32","author":"Rana","year":"2013","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2023.10.002_bib114","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib115","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.119.13642","article-title":"Effects of interleukin-1\u03b2 inhibition on blood pressure, incident hypertension, and residual inflammatory risk: a secondary analysis of CANTOS","volume":"75","author":"Rothman","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.10.002_bib116","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.10.002_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114790","article-title":"TNF\u03b1 blockade reverses vascular and uteroplacental matrix metalloproteinases imbalance and collagen accumulation in hypertensive pregnant\u00a0rats","volume":"193","author":"Ren","year":"2021","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ajog.2023.10.002_bib118","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/10641955.2015.1032054","article-title":"IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia","volume":"34","author":"Harmon","year":"2015","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2023.10.002_bib119","doi-asserted-by":"crossref","first-page":"R165","DOI":"10.1152\/ajpregu.00167.2018","article-title":"Interleukin-4 supplementation improves the pathophysiology of hypertension in response to\u00a0placental ischemia in RUPP rats","volume":"316","author":"Cottrell","year":"2019","journal-title":"Am J Physiol\u00a0Regul Integr Comp Physiol"},{"key":"10.1016\/j.ajog.2023.10.002_bib120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-20-0397","article-title":"Cytokine concentrations direct endothelial function in pregnancy and preeclampsia","volume":"248","author":"Mauro","year":"2021","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.ajog.2023.10.002_bib121","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib122","doi-asserted-by":"crossref","first-page":"S867","DOI":"10.1016\/j.ajog.2021.11.019","article-title":"Progress in the understanding of the pathophysiology of immunologic maladaptation related\u00a0to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia","volume":"226","author":"Robillard","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib123","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/oby.2006.93","article-title":"Elevated serum monocyte chemoattractant protein-4 and chronic inflammation in overweight subjects","volume":"14","author":"Hashimoto","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.ajog.2023.10.002_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029524","article-title":"Functional polymorphism of IL-1 alpha and its potential role in obesity in humans and mice","volume":"6","author":"Um","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.10.002_bib125","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cyto.2012.12.022","article-title":"Correlation of MCP-4 and high-sensitivity C-reactive protein as a marker of inflammation in obesity and chronic periodontitis","volume":"61","author":"Pradeep","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.ajog.2023.10.002_bib126","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cyto.2016.09.007","article-title":"Low-grade inflammation markers in children and\u00a0adolescents: influence of anthropometric characteristics and CRP and IL6 polymorphisms","volume":"88","author":"Todendi","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.ajog.2023.10.002_bib127","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000650","article-title":"Interleukin-1\u03b1 deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice","volume":"7","author":"Almog","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.ajog.2023.10.002_bib128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/ITT.S262566","article-title":"GM-CSF: a promising target in inflammation and autoimmunity","volume":"9","author":"Lee","year":"2020","journal-title":"Immunotargets Ther"},{"key":"10.1016\/j.ajog.2023.10.002_bib129","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ajog.2005.06.041","article-title":"The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia","volume":"193","author":"Hendler","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib130","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.ajog.2006.04.003","article-title":"Hypoadiponectinemia and circulating angiogenic factors in overweight patients complicated with pre-eclampsia","volume":"195","author":"Suwaki","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/jpm.2009.140","article-title":"Retinol binding protein 4\u2014a novel association with early-onset preeclampsia","volume":"38","author":"Vaisbuch","year":"2010","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib132","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3109\/10641955.2013.872252","article-title":"The imbalance of circulating angiogenic\/antiangiogenic factors is mild or absent in obese women destined to develop preeclampsia","volume":"33","author":"Carbillon","year":"2014","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2023.10.002_bib133","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/10998004231178835","article-title":"Apelin and visfatin expression in placental tissue in women with preeclampsia and overweight\/obesity","volume":"25","author":"Braga","year":"2023","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.ajog.2023.10.002_bib134","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1515\/jpm-2022-0474","article-title":"One-third of patients with eclampsia at term do not have an abnormal angiogenic profile","volume":"51","author":"Chaiworapongsa","year":"2023","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2023.10.002_bib135","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1471-0528.2006.00882.x","article-title":"Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction","volume":"113","author":"Egbor","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.10.002_bib136","doi-asserted-by":"crossref","first-page":"597.e1","DOI":"10.1016\/j.ajog.2009.06.024","article-title":"Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia","volume":"201","author":"Wikstr\u00f6m","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.10.002_bib137","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/1933719109339348","article-title":"Increased circulating levels of the antiangiogenic factor endostatin in early-onset but not late-onset preeclampsia","volume":"16","author":"Wikstr\u00f6m","year":"2009","journal-title":"Reprod Sci"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823007317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:40:55Z","timestamp":1777336855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823007317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":137,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0002937823007317"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.10.002","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}